Cancer and Obesity become the Underlying Cause of Booming Transfection Technology Market across the Globe
A new research report published by Transparency Market Research states that the global transfection technology market will grow rapidly in the next four years due to increasing incidence of cancer and the growing population of the obese. According to the recent market research report, titled “Transfection Technology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, the global transfection technology market was valued at US$386.4 mn in 2012 and is expected to reach US$768.2 mn by 2019, growing at a CAGR of 9.70% from 2013 to 2019.
Browse the full Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at https://www.transparencymarketresearch.com/transfection-technology.html
The global transfection technology market is segmented on the basis of method, application, and geography. The methods used in the transfection technology market are reagent-based methods, instrument-based methods, and virus-based methods. The reagent-based methods segment is further segmented into calcium phosphate, catonic polymers, DEAE-dextran, activated dendrimers, magnetic beads, and lipid mediated transfection (Lipofection). The instrument-based methods segment is divided into microinjection, laserfection, biolistic technology, and electroporation. The applications of transfection technology are seen in biomedical research, therapeutic delivery, and protein production. The biomedical research segment is further segmented into cancer research, transgenic models, gene and protein expression studies, and cell-based microarrays for drug discovery and development. On the other hand, the therapeutic delivery segment is sub-segmented into electro-chemotherapy and electro-immunotherapy and biotherapeutics. Geographically, this market is segmented into North America, Asia Pacific, Europe, and Rest of the World.
According to this research study, North America held a share of over 45% in 2012 in the global transfection technology market. The factors driving the transfection technology market in North America are increasing awareness about its applications and government initiatives. Europe held the second largest share in the global transfection technology market in 2012. Factors driving the market in Europe were the rising use of nanomedicine in diagnostics, clinical trials, drug development studies, and targeted drug delivery. In the coming years, the Asia Pacific region is anticipated to grow at a high CAGR of 10%. This development will mainly be due to the growing prevalence of infectious diseases and use of biopharmaceuticals for drug discovery and development.
The research report on the global transfection technology market profiles some of the important players in the industry, such as SignaGen Laboratories, Sigma Aldrich Corporation, Life Technologies, Lonza Group Ltd., Promega Corporation, Bio-Rad Laboratories Inc., and QIAGEN. The report give a comprehensive overview of the competitive landscape along with pointing out the market drivers, restraints, opportunities, and threats with the help of a SWOT analysis and Porter’s five forces analysis. The report also gives an insight into the company profiles and their financial overview, research and development status, list of existing products and those in the pipeline, and investment outlook.
The transfection technology market is segmented into the following categories:
- Transfection technology market, by Methods
- Reagent Based Method
- Lipid mediated transfection (Lipofection)
- Calcium phosphate
- Catonic polymers
- Activated dendrimers
- Magnetic beads
- Instrument Based Method
- Biolistic technology
- Virus Based Method
- Reagent Based Method
- Transfection Technology Market, by Applications
- Bio-medical Research
- Transgenic models
- Cancer Research
- Gene and protein expression studies
- Cell based microarrays for drug discovery and development
- Therapeutic Delivery
- Electro-chemotherapy and electro-immunotherapy
- Protein Production
- Bio-medical Research
- Transfection Technology Market, by Geography
- North America
- Rest of The World
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC